Volume 27, Number 12—December 2021
Dispatch
Evidence of Human Exposure to Tamdy Virus, Northwest China
Table 2
Patient characteristics | Serum samples, no. | TAMV IgG positive, % | TAMV IgM positive, % | Neutralization activity, % | Neutralization titers |
---|---|---|---|---|---|
Sex | |||||
M | 20 | 3 (15.0) | 7 (35.0) | 1 (5.0) | 64 |
F | 29 | 6 (20.7) | 5 (17.2) | 3 (10.3) | 16, 32, 32 |
NA |
38 |
12 (31.6) |
5 (13.6) |
2 (5.3) |
16, 16 |
Age, y† | |||||
<18 | 6 | 2 (33.3) | 1 (16.7) | 0 | |
18–30 | 20 | 1 (5.0) | 8 (40.0) | 1 (5.0) | 16 |
31–45 | 7 | 2 (28.6) | 1 (14.3) | 0 | |
46–60 | 11 | 2 (18.2) | 0 | 1 (9.1) | 32 |
>60 |
5 |
2 (40.0) |
2 (40.0) |
2 (40.0) |
32, 64 |
Total | 87 | 21 (24.1) | 17 (19.5) | 6 (6.9) | 16–64 |
*NA, not available; TAMV, Tamdy virus. †Age stratification based on 49 patients with recorded age information
1These authors contributed equally to this article.
Page created: November 09, 2021
Page updated: November 19, 2021
Page reviewed: November 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.